Navigation Links
The MDS foundation supports vidaza's recommendation for European approval
Date:10/27/2008

The Myelodysplastic Syndromes (MDS) Foundation supports the positive opinion from the European Union's Committee for Medicinal Products for Human Use (CHMP) recommending approval of VIDAZA (azacitidine) for specific types of MDS patients, including those with high-risk MDS, chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).

The CHMP positive opinion was based upon data from the AZA-001 trial, which found that VIDAZA nearly doubled the two-year survival rate for higher-risk MDS patients compared to conventional care regimens (CCR) with a mean survival of 24.5 months compared to 15 months for patients who received CCR.

"We are very encouraged by the CHMP's recommendation for marketing approval for VIDAZA," said Kathy Heptinstall, Operating Director of the Myelodysplastic Syndromes Foundation, "The MDS Foundation is committed to making sure that patients in need are aware of and have access to new treatments, like VIDAZA, that can help patients to live longer and allow them to have a better quality of life."

The AZA-001 trial also showed that, VIDAZA delays the progression of MDS to acute myeloid leukemia (AML). Roughly 30 percent of patient diagnosed with MDS will progress to AML. The delay in progression is especially significant because patients with MDS are typically over the age of 65. According to the National Institute of Health, in this patient group, the average 5-year survival rate after diagnosis with AML is only approximately four percent.

MDS is a primary neoplasm of the bone marrow that is more prevalent than any of the leukemias. MDS affects the function of blood cells; red blood cells, white blood cells or platelets. The incidence of MDS is underestimated.


'/>"/>

Contact: Kathy Heptinstall
kheptinstall@MDS-Foundation.org
800-637-0839
The Myelodysplastic Syndromes Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. Meyskens honored with AACR-Prevent Cancer Foundation award
2. Parkinsons Disease Foundation announces award of $150,000
3. The Camille & Henry Dreyfus Foundation to host important symposium on chemistry and the environment
4. UT Southwestern researcher awarded Gates Foundation grant for novel vaccine development
5. National Science Foundation grant expands UMCES oyster research
6. Dunn Foundation gives Rice $3M for collaborative research grants
7. National Science Foundation grants Clemson professors award to develop nanoprobes
8. Entertainment Software Association Foundation awards grant to FAS for immune attack
9. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
10. UT Knoxville wins 2 $3M National Science Foundation research and education grants
11. The MDS Foundation supports the FDAs decision to expand vidaza label to include survival data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2020)... ... June 25, 2020 , ... ... today announced that it has entered into a multi-year contract with Merus ... support their translational and clinical research strategy to discover and develop ground-breaking ...
(Date:6/23/2020)... ... 2020 , ... The field of quantitation of large molecules or proteins has ... area. However, the use of mass spectrometry in this field has gained a lot ... do you choose which approach to use (LBA or MS)?” In many cases, ...
(Date:6/19/2020)... (PRWEB) , ... June 18, 2020 , ... Join experts ... Zhao, PhD, Principal Scientist in a live webinar on Wednesday, July 8, ... have simplified the way we genetically engineer new models. However, while modifying the genome ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... ... May 12, 2020 , ... DuPont ... new distribution partner for all personal care ingredients in Russia and Belarus. Beginning ... DuPont preservative portfolio for personal care. , The GENENCARE®OSMS product line ...
(Date:5/14/2020)... ... May 13, 2020 , ... In collaboration ... Optimizing Workflows in the Life Science Lab . The comprehensive information source was ... water purification and liquid handling to contamination control. , The content hub features ...
(Date:5/9/2020)... ... ... Worldwide Business with kathy ireland® will be LIVE streaming ... Wednesday, May 13, 2020 at 8:00pm ET / PT – prime time viewings ... Techolution and Bravado Pharmaceuticals . , As leaders in their industries, ...
(Date:5/5/2020)... , ... May 05, 2020 , ... ProductLife Group ... high-profile CEO. Xavier Duburcq joins the group after 13 years at Altran, where he ... Holding a PhD in Immunology and being a Pharmacist, Xavier was involved in his ...
Breaking Biology Technology: